Edwards Lifesciences Hurt by Competition

Before you go, we thought you'd like these...
Before you go close icon

At The Motley Fool, we know our readers like to be informed. Here's a quick look at today's most relevant financial news, boiled down to what you need to know. In today's video, we cover the following:

  • Edwards Lifesciences (NYS: EW) , which makes heart valves, showed flat sales in the U.S. for its last quarter as competing products entered the market.
  • Acme Packet (NAS: APKT) , a company making devices that transmit data over the Internet, reported earnings slightly below estimates.
  • AON's (NYS: AON) human resources segment lifted profits in the company's fourth quarter.
  • Sunoco (NYS: SUN) says goodbye to its CEO after reporting a loss of $660 million before taxes.

For many companies, performance abroad is a major concern in the year ahead. That's why I encourage you to read this special free report from The Motley Fool, which highlights three stocks that are driving profits in emerging markets: "3 American Companies Set to Dominate the World." To get your free copy now, click here.

At the time this article was published Fool contributor Tamara Rutter does not own shares of any companies mentioned in this video. Follow her on Twitter for more Foolish news @TamaraRutter. The Motley Fool owns shares of Aon. Motley Fool newsletter services have recommended buying shares of Acme Packet and Aon. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners